Memorial Hermann And Contessa Partner To Provide Patients New At-Home Care Options [TheStreet.com]
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: TheStreet.com
HOUSTON and NASHVILLE, Tenn., June 24, 2022 (GLOBE NEWSWIRE) -- is pleased to announce a new partnership with the nation's leading high-acuity home care provider Contessa, an Amedisys company ( ) -, to deliver home-based medical, rehabilitation and palliative care to its patients. Through the partnership, Memorial Hermann will be able to offer acute hospital care, post-hospitalization skilled nursing care, and palliative care to patients from the convenience of their own homes, rather than only the traditional brick-and-mortar inpatient or rehabilitation facilities. Contessa's hospital care at home model is proven to reduce readmission rates by 44 percent, decrease hospital length of stay by 35 percent, and achieve a patient satisfaction rate of more than 90 percent. "Our new partnership with Contessa exemplifies Memorial Hermann's commitment to deploying innovative care models by transforming our service lines to put the patient experience front and center," said Dr. David Callende
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.MarketBeat
- UnitedHealth deal for Amedisys likely to close despite report of DOJ scrutiny - analyst [Seeking Alpha]Seeking Alpha
- Why Amedisys (AMED) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 3/19/24 - Form 8-K
- 2/22/24 - Form 10-K
- 2/21/24 - Form 4
- AMED's page on the SEC website